Regeneron expects FDA decision on high-dose eye drug this year, shares jump
(Reuters) -Regeneron Pharmaceuticals expects a U.S. decision on a higher-dose version of its blockbuster eye disease drug Eylea in the…
Uncategorized
US layoffs fall to lowest level in nearly a year
By Safiyah Riddle (Reuters) – American employers announced fewer layoffs in July than the year before, marking the first year-over-year…
India’s services growth at 13-year high in July on strong demand
By Shaloo Shrivastava BENGALURU (Reuters) – India’s dominant services sector expanded at its fastest pace in 13 years last month…
Sluggish return of business travelers forces US airlines to rejig their networks
By Rajesh Kumar Singh CHICAGO (Reuters) -U.S. airlines are enjoying strong leisure travel demand, but corporate travelers are still not…
Holiday travel boom here to stay, says Lufthansa
By Maria Sheahan BERLIN (Reuters) – The boom in holiday travel shows no signs of ending, German airline group Lufthansa…
Brazil’s Ambev Q2 net profit falls 15%, lands below estimates
By Natalia Siniawski (Reuters) -Brazilian brewer Ambev on Thursday reported a 15.2% decline in second-quarter net profit, narrowly missing market…
Apollo’s second-quarter earnings surge 75% on upbeat annuities business
By Chibuike Oguh NEW YORK (Reuters) – Apollo Global Management Inc said on Thursday its second-quarter adjusted net income jumped…
US psychiatrists prescribe Wegovy to battle medication-induced weight gain
By Elissa Welle NEW YORK (Reuters) – U.S. psychiatrists are increasingly prescribing the popular weight-loss drug Wegovy to patients who…
Redistricting battles could determine control of US House in 2024
By Joseph Ax NEW YORK (Reuters) – Brewing battles over redistricting from New York to Utah may result in new…
What is your magic retirement number?
By Chris Taylor NEW YORK (Reuters) – How much money do you really need for retirement? One guess is $1.27…